Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRGF for Diabetic Foot Ulcers with PAD
NCT06952998Phase 4Recruiting
- Sponsor
- BTI Biotechnology Institute
- Start
- Nov 2025
- Primary completion
- May 2026
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
A Phase 4 trial of PRGF-Endoret in diabetic foot ulcer (DFU), sponsored by BTI Biotechnology Institute. Started Nov 2025; status: recruiting.
02
Drugs
PRGF-Endoret
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on NCT06952998.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06952998.